Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LBPH | US
2.96
9.28%
Healthcare
Biotechnology
31/03/2024
05/07/2024
34.87
32.07
35.59
31.59
Longboard Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352 which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352 LP659 LP143 and other compounds. The company was formerly known as Arena Neuroscience Inc. and changed its name to Longboard Pharmaceuticals Inc. in October 2020. Longboard Pharmaceuticals Inc. was incorporated in 2020 and is based in La Jolla California.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
114.7%1 month
97.2%3 months
83.9%6 months
75.1%-
-
18.24
0.01
0.01
-12.30
-
-
-62.90M
1.36B
1.36B
-
-
-
-
-30.04
15.31
14.30
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
15.93
Range1M
19.95
Range3M
19.95
Rel. volume
1.14
Price X volume
26.46M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Akero Therapeutics Inc | AKRO | Biotechnology | 21.45 | 1.48B | -2.19% | n/a | 4.28% |
Dynavax Technologies Corporation | DVAX | Biotechnology | 11.25 | 1.47B | 2.09% | 160.43 | 41.41% |
Array BioPharma Inc | ARRY | Biotechnology | 9.62 | 1.46B | -4.85% | 27.00 | 114.13% |
Avadel Pharmaceuticals plc | AVDL | Biotechnology | 14.78 | 1.42B | 1.72% | n/a | 46.87% |
MannKind Corporation | MNKD | Biotechnology | 5.13 | 1.40B | 1.99% | 130.50 | -162.73% |
Bicycle Therapeutics Limited | BCYC | Biotechnology | 20.21 | 1.39B | 3.22% | n/a | 12.31% |
Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 19.36 | 1.37B | 1.36% | 143.62 | 2.81% |
Belite Bio Inc | BLTE | Biotechnology | 45.5 | 1.36B | -0.55% | n/a | 0.00% |
BioCryst Pharmaceuticals Inc | BCRX | Biotechnology | 6.52 | 1.35B | 1.72% | n/a | -173.65% |
Verona Pharma plc | VRNA | Biotechnology | 16.11 | 1.31B | 2.55% | n/a | 22.79% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Steelcase Inc | SCS | Building Products & Equipment | 12.82 | 1.46B | -0.93% | 17.05 | 69.98% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.45 | 1.31B | -0.37% | n/a | 20.15% |
REV Group Inc | REVG | Recreational Vehicles | 24.74 | 1.28B | -2.06% | 5.86 | 66.74% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.36 | 1.14B | 1.60% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -12.30 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 18.24 | 22.34 | Par |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 83.91 | 76.52 | Par |
Debt to Equity | 0.01 | 0.51 | Cheaper |
Debt to Assets | 0.01 | 0.24 | Cheaper |
Market Cap | 1.36B | 3.77B | Emerging |